SCHEMBL70007

SCHEMBL70007

CCCCCc1c(O)cccc1O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.52
NPC1 O15118 1/20 0.52
HPGD P15428 1/20 0.52
MAPK1 P28482 1/20 0.52
RAB9A P51151 1/20 0.52
NPSR1 Q6W5P4 1/20 0.52
BID P55957 3/20 0.51
MCL1 Q07820 3/20 0.51
BCL2L1 Q07817 2/20 0.51
BAK1 Q16611 2/20 0.51
KAT8 Q9H7Z6 2/20 0.51
PPARG P37231 1/20 0.51
PPARA Q07869 1/20 0.51
EP300 Q09472 1/20 0.51
KAT2A Q92830 1/20 0.51
KAT2B Q92831 1/20 0.51
KAT5 Q92993 1/20 0.51
SAE1 Q9UBE0 1/20 0.51
ALDH1A1 P00352 2/20 0.48
TYR P14679 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31545728 1.00 HTT (0.52) HTTNPC1HPGDMAPK1RAB9A
SCHEMBL876099 0.98 BID (0.54) HTTNPC1HPGDMAPK1RAB9A
SCHEMBL22501541 0.98 BID (0.54) HTTNPC1HPGDMAPK1RAB9A
SCHEMBL29108 0.98 BID (0.54) HTTNPC1HPGDMAPK1RAB9A
SCHEMBL9784636 0.98 BID (0.54) HTTNPC1HPGDMAPK1RAB9A
SCHEMBL17938799 0.98 BID (0.54) HTTNPC1HPGDMAPK1RAB9A
SCHEMBL16528762 0.98 BID (0.54) HTTNPC1HPGDMAPK1RAB9A
SCHEMBL70428 0.98 BID (0.54) HTTNPC1HPGDMAPK1RAB9A
SCHEMBL2370347 0.98 BID (0.54) HTTNPC1HPGDMAPK1RAB9A
SCHEMBL31545793 0.98 BID (0.54) HTTNPC1HPGDMAPK1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 589 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12053537-B2 Reduction of stinging sensation on skin SYMRISE AG (DE) 2024-08-06 US claimed
CN-108472220-B Reducing the perception of skin stinging 西姆莱斯股份公司 2022-06-17 CN claimed
EP-3373895-B1 REDUCTION OF STINGING SENSATION ON SKIN SYMRISE AG (DE) 2020-08-19 EP claimed
CN-104414869-B A kind of skin and/or hair whitening mixture 西姆莱斯股份公司 2019-09-03 CN claimed
CN-109988213-A A kind of compound and its preparation method and application for peptide synthesis in liquid phase carrier 深圳翰宇药业股份有限公司 2019-07-09 CN claimed
EP-3373895-A1 REDUCTION OF STINGING SENSATION ON SKIN Symrise AG (DE) 2018-09-19 EP claimed
EP-2842607-B1 A skin and/or hair whitening mixture SYMRISE AG (DE) 2018-05-30 EP claimed
WO-2017080625-A1 REDUCTION OF STINGING SENSATION ON SKIN SYMRISE AG (DE) 2017-05-18 WO claimed
CN-104414869-A SKIN AND/OR HAIR WHITENING MIXTURE SYMRISE AG 2015-03-18 CN claimed
US-20150064122-A1 SKIN AND/OR HAIR WHITENING MIXTURE SYMRISE AG (DE) 2015-03-05 US claimed
CN-1736974-A Special alembic for disposing vinyl acetate waste slag of alembic bottom and waste slag processing method WAN XIAOWEN (CN) 2006-02-22 CN claimed
WO-2005107456-A2 ANTIMICROBIAL SILICON OXIDE FLAKES CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2005-11-17 WO claimed
EP-1537201-A1 HARD SURFACE TREATING COMPOSITIONS Reckitt Benckiser Inc. (US) 2005-06-08 EP claimed
WO-2004024861-A1 HARD SURFACE TREATING COMPOSITIONS RECKITT BENCKISER INC (US) 2004-03-25 WO claimed
WO-2003082948-A1 A METHOD OF ALIGNING POLYMER CHAINS TEKNILLINEN KORKEAKOULU (FI) 2003-10-09 WO claimed
EP-0331422-A2 Method of preparing 2-acylresorcinols MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1989-09-06 EP claimed
EP-0021716-B1 CONDENSATION PRODUCT AND LITHOGRAPHIC PRINTING PLATES CONTAINING SAID PRODUCT KONICA CORPORATION (JP) 1984-02-15 EP claimed
EP-0001617-B1 DIAZOTYPE MATERIAL HOECHST AKTIENGESELLSCHAFT (DE) 1981-07-22 EP claimed
US-4207110-A 2,5-DIALKOXY-4-MORPHOLINO-BENZENE DIAZONIUM SALT AND COUPLER COMBINATION TO GIVE BLACK IMAGE HOECHST AKTIENGESELLSCHAFT (DE) 1980-06-10 US claimed
EP-0001617-A1 Diazotype material HOECHST AKTIENGESELLSCHAFT (DE) 1979-05-02 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12053537-B2 Reduction of stinging sensation on skin STING1, TYR, CUTA HTT 4421/4885NPC1 1983/4885HPGD 1478/4885
US-20150064122-A1 SKIN AND/OR HAIR WHITENING MIXTURE TYR, AHR, CYP1B1 HTT 1679/4885NPC1 3089/4885HPGD 1470/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.